224 related articles for article (PubMed ID: 20812931)
1. Sodium channelopathies: do we really understand what's going on?
Postema PG; Mosterd A; Hofman N; Alders M; Wilde AA
J Cardiovasc Electrophysiol; 2011 May; 22(5):590-3. PubMed ID: 20812931
[TBL] [Abstract][Full Text] [Related]
2. Channelopathies: a new category of diseases causing sudden death.
Brugada J; Brugada R; Brugada P
Herz; 2007 May; 32(3):185-91. PubMed ID: 17497250
[TBL] [Abstract][Full Text] [Related]
3. Patient with obstructive sleep apnea-hypopnea syndrome and SCN5A mutation (R1193Q polymorphism) associated with Brugada type 2 electrocardiographic pattern.
Qiu X; Liu W; Hu D; Sun Y; Li L; Li C
J Electrocardiol; 2009; 42(3):250-3. PubMed ID: 18976777
[TBL] [Abstract][Full Text] [Related]
4. Cardiac sodium channel overlap syndromes: different faces of SCN5A mutations.
Remme CA; Wilde AA; Bezzina CR
Trends Cardiovasc Med; 2008 Apr; 18(3):78-87. PubMed ID: 18436145
[TBL] [Abstract][Full Text] [Related]
5. A heterozygous deletion mutation in the cardiac sodium channel gene SCN5A with loss- and gain-of-function characteristics manifests as isolated conduction disease, without signs of Brugada or long QT syndrome.
Zumhagen S; Veldkamp MW; Stallmeyer B; Baartscheer A; Eckardt L; Paul M; Remme CA; Bhuiyan ZA; Bezzina CR; Schulze-Bahr E
PLoS One; 2013; 8(6):e67963. PubMed ID: 23840796
[TBL] [Abstract][Full Text] [Related]
6. Genetic modulation of brugada syndrome by a common polymorphism.
Lizotte E; Junttila MJ; Dube MP; Hong K; Benito B; DE Zutter M; Henkens S; Sarkozy A; Huikuri HV; Towbin J; Vatta M; Brugada P; Brugada J; Brugada R
J Cardiovasc Electrophysiol; 2009 Oct; 20(10):1137-41. PubMed ID: 19549036
[TBL] [Abstract][Full Text] [Related]
7. Clinical heterogeneity in sodium channelopathies. What is the meaning of carrying a genetic mutation?
Oliva A; Bjerregaard P; Hong K; Evans S; Vernooy K; McCormack J; Brugada J; Brugada P; Pascali VL; Brugada R
Cardiology; 2008; 110(2):116-22. PubMed ID: 17971661
[TBL] [Abstract][Full Text] [Related]
8. SCN5A channelopathies--an update on mutations and mechanisms.
Zimmer T; Surber R
Prog Biophys Mol Biol; 2008; 98(2-3):120-36. PubMed ID: 19027780
[TBL] [Abstract][Full Text] [Related]
9. The occurrence of Brugada syndrome and isolated cardiac conductive disease in the same family could be due to a single SCN5A mutation or to the accidental association of both diseases.
Six I; Hermida JS; Huang H; Gouas L; Fressart V; Benammar N; Hainque B; Denjoy I; Chahine M; Guicheney P
Europace; 2008 Jan; 10(1):79-85. PubMed ID: 18156160
[TBL] [Abstract][Full Text] [Related]
10. A sodium channel pore mutation causing Brugada syndrome.
Pfahnl AE; Viswanathan PC; Weiss R; Shang LL; Sanyal S; Shusterman V; Kornblit C; London B; Dudley SC
Heart Rhythm; 2007 Jan; 4(1):46-53. PubMed ID: 17198989
[TBL] [Abstract][Full Text] [Related]
11. A novel mutation in the SCN5A gene is associated with Brugada syndrome.
Shin DJ; Kim E; Park SB; Jang WC; Bae Y; Han J; Jang Y; Joung B; Lee MH; Kim SS; Huang H; Chahine M; Yoon SK
Life Sci; 2007 Jan; 80(8):716-24. PubMed ID: 17141278
[TBL] [Abstract][Full Text] [Related]
12. [Novel SCN5A gene mutations associated with Brugada syndrome: V95I, A1649V and delF1617].
Liang P; Liu WL; Hu DY; Li CL; Tao WH; Li L
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Jul; 34(7):616-9. PubMed ID: 17081365
[TBL] [Abstract][Full Text] [Related]
13. Dual phenotypic transmission in Brugada syndrome.
Hermida JS; Arnalsteen-Dassonvalle E; Kubala M; Mathiron A; Traulle S; Anbazhagan K; Hermida A; Rochette J
Arch Cardiovasc Dis; 2013; 106(6-7):366-72. PubMed ID: 23810369
[TBL] [Abstract][Full Text] [Related]
14. [Inherited cardiac diseases caused by Nav1.5 sodium channel mutations].
Tfelt-Hansen J; Olesen SP; Svendsen JH; Jespersen T
Ugeskr Laeger; 2009 Apr; 171(15):1261-5. PubMed ID: 19416615
[TBL] [Abstract][Full Text] [Related]
15. A mutation in the human cardiac sodium channel (E161K) contributes to sick sinus syndrome, conduction disease and Brugada syndrome in two families.
Smits JP; Koopmann TT; Wilders R; Veldkamp MW; Opthof T; Bhuiyan ZA; Mannens MM; Balser JR; Tan HL; Bezzina CR; Wilde AA
J Mol Cell Cardiol; 2005 Jun; 38(6):969-81. PubMed ID: 15910881
[TBL] [Abstract][Full Text] [Related]
16. Analyses of a novel SCN5A mutation (C1850S): conduction vs. repolarization disorder hypotheses in the Brugada syndrome.
Petitprez S; Jespersen T; Pruvot E; Keller DI; Corbaz C; Schläpfer J; Abriel H; Kucera JP
Cardiovasc Res; 2008 Jun; 78(3):494-504. PubMed ID: 18252757
[TBL] [Abstract][Full Text] [Related]
17. Criteria to predict carriers of a novel SCN5A mutation in a large Portuguese family affected by the Brugada syndrome.
Santos LF; Rodrigues B; Moreira D; Correia E; Nunes L; Costa A; Elvas L; Pereira T; Machado JC; Castedo S; Henriques C; Matos A; Santos JO
Europace; 2012 Jun; 14(6):882-8. PubMed ID: 22277643
[TBL] [Abstract][Full Text] [Related]
18. Provocation of silence.
van Opstal JM; Volders PG; Crijns HJ
Europace; 2009 Mar; 11(3):385-7. PubMed ID: 19181867
[TBL] [Abstract][Full Text] [Related]
19. Mouse models of SCN5A-related cardiac arrhythmias.
Charpentier F; Bourgé A; Mérot J
Prog Biophys Mol Biol; 2008; 98(2-3):230-7. PubMed ID: 19041666
[TBL] [Abstract][Full Text] [Related]
20. Developmental aspects of long QT syndrome type 3 and Brugada syndrome on the basis of a single SCN5A mutation in childhood.
Beaufort-Krol GC; van den Berg MP; Wilde AA; van Tintelen JP; Viersma JW; Bezzina CR; Bink-Boelkens MT
J Am Coll Cardiol; 2005 Jul; 46(2):331-7. PubMed ID: 16022964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
